Laurus Labs gets EIR from USFDA for unit 6 in Andhra Pradesh

04 Feb 2019 Evaluate

Laurus Labs has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its Unit 6 on February 2, 2019. The manufacturing unit 6 was inspected by the regulatory agency in the month of November 2018 and is located at APSEZ, Atchutapuram, Visakhapatnam in the state of Andhra Pradesh.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

586.40 15.60 (2.73%)
27-Dec-2024 15:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1391.35
Cipla 1506.35
Lupin 2227.60
Zydus Lifesciences 972.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.